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Summary 
T  cells of mice display V~-specific reactivity for a spectrum of mouse mammary tumor virus 
(Mtv) antigens; confrontation with these antigens during ontogeny causes substantial "holes" 
in the T  cell repertoire. Since endogenous Mtv antigens are rare in other species, the question 
arises whether V~-specific recognition of Mtv antigens is unique to mice. To examine this question, 
rat T  cells were allowed to differentiate from stem cells in severe combined immunodeficiency 
(SCID) mice. These rat --~ mouse xenochimeras were prepared under a variety of conditions. 
The results  show that rat T  cells are strongly reactive to mouse Mtv antigens, both in terms 
of tolerogenicity and immunogenicity,  tn fact, the VB specificity of rat and mouse T  cells for 
Mtv  antigens  is almost  indistinguishable. 
T 
he evidence that self-tolerance is at least partly a reflec- 
tion of clonal deletion in the thymus has come largely 
from studies on endogenous mouse mammary tumor viruses 
(Mtv) 1 (1-4).  T  cell responses to mouse Mtv  antigens  are 
TCR V/3-specific (1-4), and intrathymic contact with these 
antigens causes V/~-specific clonal deletion of T  cells (5-6). 
Since most mouse strains express a spectrum of different Mtv 
antigens, VB-specific deletion of T  cells is very common in 
mice. However, in other species, notably rats and humans, 
endogenous Mtv antigens  are rare or absent,  and VB dele- 
tion in these species is inconspicuous (7, 8). This raises the 
question whether T cell specificity for Mtv antigens is unique 
to mice. In a recent study in which human T  cells differen- 
tiated in human  thymus fragments  grafted to SCID  mice, 
contact with the mouse Mtv antigens of the host failed to 
cause V~-specific deletion of the human  T  cells  (9).  This 
finding is di~cult  to interpret, however, because human T 
cells interact poorly with mouse APC  (10).  A  subsequent 
study by a different group found that  fresh human T  cells 
were able to respond to mouse Mtv-7 antigens provided that 
the antigens were presented in association with a human class 
II molecule  (11). 
In this paper we have studied whether rat T cells can recog- 
nize mouse Mtv antigens. With the aid of rat --,- SCID mouse 
chimeras, we show here that rat T  cells are indeed strongly 
reactive to Mtv antigens, both in terms of tolerogenicity and 
immunogenicity. 
1 Abbreviations used in thispaper: F344, Fisher 344; FL, fetal liver; LEW, 
Lewis; Mtv, mammary tumor virus. 
Materials and Methods 
Animals.  C.B-17  SCID,  BALB/c,  DBA/2,  C57BL/6,  and 
B10.BR mice were obtained from the breeding colony of the Scripps 
Research  Institute.  Mtv-7 +  (Mls ~)  (Mls-1 ~)  BALB/c congeneic 
BALB.D2 mice (12) were bred at the Scripps Institute from a set 
of breeding pairs kindly provided by Dr. Richard Hodes at the Na- 
tional Institutes of Health. Adult and timed-pregnant Lewis (LEW) 
rats were obtained from the Scripps Institute.  Timed-pregnant Fisher 
344 (F344) rats were purchased from Harlan Sprague Dawley, Inc. 
(Indianapolis,  IN). 
mAbs.  The following mAbs to rat TCR V/~ chains were used: 
R78  (anti-VB  8.2)  (13); G101 (anti-V~/  10)  (13);  and  HIS-42 
(anti-V/~ 16) (14). MAbs to rat T cells subsets, OX-38 (anti-CD4) 
and OX-8 (anti-CD8), and a mAb to mouse T cells, Jlj (anti-Thy- 
1.2) were previously described (15, 16). 
Preparation of Rat -* Mouse Chimeras.  Using a modification of 
a technique described previously (15), neonatal C.B-17 SCID mice 
were injected intravenously within 48 h of birth with gestation 
day 15-17 rat fetal liver (FL) cells. A total of 107 cells was injected 
into the anterior facial vein in a 100-ftl volume using a 30-gauge 
needle. Some neonatal SCID mice received a mixture of 107 fetal 
liver cells and 5  x  106 LPS-activated B cells; LPS-activated B ceUs 
were generated by incubating  anti-Thy-l.2 mAb  +  C'  treated 
(T-depleted) LN cells with 50 ftg/ml LPS for 24 h. The chimeras 
were used  at least  5 wk after injection. 
Analysis of Rat V~ mRNA  Content.  Total cellular  RNA was 
isolated  from LN cells and cDNA was synthesized as previously 
described (17). After cDNA synthesis, amplification of cDNA was 
performed with a modification of a previously described method 
(17). Briefly, cDNA was transferred to a tube containing the fol- 
lowing: a rat TCR CB primer (0.6 ftM); 5'TGCGAGGATTGT- 
GCCAGAAG Y, which is internal to C/~-E used in cDNA syn- 
thesis; dNTPs (200/~M);  and Taq DNA polymerase (23 U; Perkin 
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with 1.5 mM MgCla. Aliquots of this mixture were added to 23 
individual wells of a microtiter plate,  each of which contained a 
VB oligonucleotide primer specific for I of the 20 known rat V3 
families or no V/~ primer as control, and PCR amplification was 
performed as previously described in a 96-well thermal cycler (MJ 
Research, Inc., Watertown, MA) (17). After amplification, aliquots 
of PCR  products were denatured,  neutralized,  and  spotted on 
nitrocellulose paper,  and UV cross-linked  to the filter. The filter 
was probed with 32p end-labeled C3-specific oligonucleotide that 
was 5' to the CB oligonucleotide used in the PCR using standard 
conditions. After the washes,  the level of hybridization for each 
VB was measured using a radioisotope detector (AMBIS, Inc., San 
Diego, CA). All values were corrected by subtracting counts in- 
corporated into the water blank control well. Relative V3 expres- 
sion was then calculated by summing all counts detected and dividing 
this value into the net counts for any given well. 
Mixed Lyrnphocyte Reaction.  Responder LN cells were cultured 
with mitomycin C-treated stimulator cells as described elsewhere 
(16). Briefly, whole LN cells at 1 or 2  x  105/well were cultured 
with 5  x  105 mitomycin C-treated whole rat LN cells or T-de- 
pleted mouse spleen cells. Cultures were harvested at 3 and 4 d 
later; cultures were pulsed with 1 gtCi [3H]TdR  8 h before harvest. 
FACS |  Analysis.  Thymocytes and LN cells were double stained 
for rat TCR VB chains and rat CD4 and analyzed on a FACScan  | 
flow cytometer (Becton Dickinson & Co., Sunnyvale, CA) as de- 
scribed  elsewhere (15). Briefly, aliquots of cell suspensions  were 
incubated with FITC-conjugated anti-rat V3 specific mAbs (R78, 
G101, and HIS-42) and PE-labeled  anti-rat CD4 (OX-38; Phar- 
Mingen, San Diego, CA) plus propidium iodide.  Cells were also 
double stained with FITC-conjugated anti-rat CD8 (OX-8; Phar- 
Mingen) and PE-OX-38. 
Results 
Production  of Rat --~ Mouse Chimeras.  We have previously 
reported that  reconstituting irradiated  adult  C.B-17  SCID 
(H-2 a) mice with rat  FL cells leads to de novo differentia- 
tion of rat T  cells in the host thymus (15). Surprisingly, the 
rat T  cells developing in these xenochimeras do not become 
tolerant to host mouse antigens,  and the recipients eventu- 
ally develop lethal graft vs. host disease; the lack of tolerance 
induction in these irradiated chimeras may reflect that host 
bone marrow (BM)-derived cells are entirely replaced by donor- 
derived cells. 
We have since found that host BM-derived cells are preserved 
when rat FL cells are transferred to nonirradiated  neonatal 
SCID mice. In this situation, the rat-derived T cells developing 
in the chimeras show strong tolerance to the host  and the 
chimeras fail to develop GVHD.  Such tolerance is demon- 
strable in vitro (Fig.  1).  Thus,  in contrast to normal LEW 
T  cells (Fig.  1 b), the rat-derived T  cells prepared from LN 
ofLEW FL --," neonatal SCID chimeras give only low MLR 
in vitro to BALB/c spleen stimulators,  i.e.,  stimulators  ex- 
pressing  the  H-2  a antigens  of the  SCID  hosts  (Fig.  1  c). 
MLR to BALB/c stimulators  are generally no higher than 
to LEW (donor) stimulators;  this contrasts with the strong 
response to third party B10.BR (H-2  k) stimulators (and also 
to DBA/2 and BALB.D2 stimulators, see below). As shown 
in Table 1, the differentiation of rat T  cells in LEW FL --* 
Normal  BALB/c 
]20000"  ~  D4 
3CI~o 
0  ~  ~ 
Lewis  BI0.BR  BALB/c BALB.D2 DBA/2 
Rtll  H-2  k  H-2  d  H-2  d  H-2  d 
MW-T  Mtv-7"  Mtv-7  +  M/v-7  + 
C  Lewis FL ->  SCID 
b  Normal Lewis 
15Go0o 
Lewls  BI0.BR BALB/c  BALB.D2 DBA/2 
d  F344 FL->  SCID 
45coo 
I  15C~0 
i  J  i 







Lewis FL +  BALB/c B cell 
blasts -> SCID 
Lewis  B10BR  BALB/c BALB.D2 DI~A~ 
6000D. 




Lewis FL +  DBA/2 B cell 
blasts -> SCID 
i  i  i  i 
Lewis  BIO.BR BALB/c BALBD2  DBAt2 
Figure  1.  Proliferative  responses of rat T cells to Mtv-7  * (Mls~) stimu- 
lator cells in primary MLR. LN responder  cells from normal BALB/c  mice 
(a), normal Lewis rats (b), and four types of rat ~  mouse chimeras (c-f) 
(see Table 1) were cultured with mitomycin C-treated Lewis rat LN cells 
or T cell-depleted B10.BR (H-2  k, Mtv-7-), BALB/c (H-2  a, Mtv-7-), 
BALB.D2 (Mtv-7  § congeneic  strain with BALB/c  background) or DBA/2 
(H-2  a, Mtv-7 +) mouse spleen cells for 3 d (D3) or 4 d (D4). Note that 
the cpm scale for (a) & (b) is different from the scale for (c-f). 
neonatal SCID chimeras is efficient, the thymus shows near- 
complete  reconstitution  with  rat-derived  cells,  and  large 
numbers  of rat  CD4  and  CD8  cells appear in LN. 
Proliferative  Response  of Rat  T  Cells  to Mtv-7  (Mls  ~) An- 
tigens.  Although many different Mtv antigens cause V3 de- 
letion in mice, strong primary proliferative responses of ma- 
ture T  cells  to Mtv  antigens  are largely limited  to Mtv-7 
(Mls  a) antigens;  these antigens are not expressed in C.B-17 
SCID mice or BALB/c mice but are expressed in H-2-com- 
patible DBA/2 mice and also in the BALB.D2 congeneic strain 
(which is nearly identical to BALB/c  except for Mtv-7 ex- 
pression). These two Mtv-7 § strains are strongly immuno- 
genic for BALB/c T  cells  (Fig.  1 a). 
Because normal rat T  cells express alloreactivity for H-2 a 
(BALB/c) (Fig. 1 b) testing whether rat T cells can recognize 
Mtv-7 antigens depends on prior removal of H-2a-reactive 
T  cells.  As  discussed  above,  these cells are depleted in rat 
FL --~ neonatal C.B-17 (H-2 a) SCID chimeras. The question 
arises,  therefore, whether  the rat T  cells from these xeno- 
chimeras are able to respond to DBA/2 and BALB.D2, i.e., 
to Mtv-7 +  stimulators.  As  shown  in  Fig.  1 c,  rat  T  cells 
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Percent  rat cells 
Cells injected  into  Time after  Organs  Cell counts 
neonatal SCID  hosts  transplantation  examined  ( ￿  10  6)  CD4  CD8  CD4 +8 §  /z 
107 Lewis FL 
107 Lewis FL  +  5  x  106 
BALB/c  (Mtv-7-)  B cell  blasts 
107 Lewis FL  +  5  x  106 
DBA/2  (Mtv-7*)  B cell blasts 
107 Fisher 344  FL 
5 wk  Thymus  80  8.6  3.4  78.9  nd* 
LN  48  56.8  17.4  2.6  23.2 
5 wk  Thymus  60  7.0  2.9  84.9  nd 
LN  37  49.0  9.5  2.8  nd 
5 wk  Thymus  20  7.6  5.2  77.9  nd 
LN  15  53.7  10.4  3.0  nd 
12 wk  Thymus  6  34.1  14.7  14.3  nd 
LN  59  55.9  21.6  2.3  16.2 
Rat "* mouse chimeras were established by intravenous injection of either 107 day-15-16 rat fetal liver (FL) cells alone or a mixture of rat FL cells 
with 5  x  106 mouse B cell blasts; cells were injected into  neonatal C.B-17 SCID (H-2  d, Mtv-7) mice within  48 h of birth.  Mouse B cell blasts 
were generated by depleting LN cells of T cells (by anti-Thy-1, anti-CD4 and anti-CD8 plus C' treatment) and incubating the surviving cells with 
LPS for 24 h. The success rates for significant engraftment  of rat lymphoid cells were >90% for SCID mice injected with only rat FL cells and 
about 50%  for mice injected with FL plus B cell blasts. In the bone marrow of xenochimeras tested after 5 wk after reconstitution,  80-90% of 
the cells were mouse CD45 +. Data shown are mean percentages of positive cells as determined by FACS  |  analysis  using specific mAbs; 
data  are averages of 2-4 mice analyzed individually. 
* Not  done. 
from LEW  FL --* SCID chimeras do indeed  give substan- 
tially  higher  responses  to  Mtv-7 +  DBA/2  and  BALB.D2 
stimulators than to Mtv-7-  BALB/c stimulators.  The same 
finding applies to the F344 rat T  cells differentiating in F344 
FL ---* SCID chimeras (Fig. 1 d ). In both situations, responses 
to Mtv-7 + stimulators reach peak levels at day 3  of culture 
and  then  decline. 
The above data indicate that, after depletion of H-2d-reac  - 
tire T  cells, rat T  cells are capable of mounting quite strong 
primary proliferative responses to Mtv-7 antigens.  Evidence 
that rat T  cells can also be specifically tolerized to Mtv-7 an- 
tigens  is  given below. 
Functional Tolerance to Mtv-7 Antigens.  To test whether rat 
T  cells can be tolerized to Mtv-7 antigens, we reconstituted 
neonatal  SCID mice with  a mixture of LEW FL cells and 
DBA/2 (Mtv-7 +) LPS-activated B cell blasts; control groups 
of mice received LEW FL cells plus BALB/c (Mtv-7-) B cell 
blasts (Table 1). As shown in Fig.  I f, including  DBA/2 B 
cell blasts in the inoculum of LEW FL cells induced strong 
tolerance to Mtv-7 antigens. Thus, the rat T  cells developing 
in  these  chimeras  were  unresponsive  not  only  to  BALB/c 
stimulators  but  also to DBA/2  and  BALB.D2  stimulators. 
For chimeras prepared with BALB/c (Mtv-7-) B cell blasts, 
by contrast,  T  cell responses were low to BALB/c but high 
to DBA/2 and BALB.D2 (Fig.  1 e). Both types of chimeras 
gave strong responses to third-party B10.BIK (H-2 k) stimu- 
lators. 
To pursue these findings, we examined whether tolerance 
induction to Mtv-7 antigens is associated with Vfl deletion. 
lift Deletion to Mtv-7.  To search for Vfl deletion in rat --* 
SCID  chimeras,  we measured  levels of rat  Vfl  mRNA  by 
a semiquantitative  PCR  method  (Materials  and Methods). 
The relative level of mRNA  for each Vfl (relative to total 
Vfl mRNA)  found in T  cells from normal LEW and F344 
rats  is  shown  in Table 2.  As discussed  elsewhere  (18),  the 
V/3 repertoire in rats and mice is quite similar, and rat Vfls 
are numbered according  to the closest mouse counterparts. 
In mice, intrathymic contact with Mtv-7 antigens causes 
deletion of T  cells expressing V/36,  7,  8.1,  and  9  (4).  The 
Vfl repertoire of rat T cells developing in LEW FL  +  DBA/2 
(Mtv-7 +) B cell blasts --~ SCID chimeras is shown in Table 
2. It is apparent that the LEW LN T cells from these chimeras 
showed  a  marked reduction  of mRNA  for Vfl6,  7,  and  9 
relative to normal LEW T  cells; there was also a marked reduc- 
tion in V~8.2 mRNA.  This pattern of Vfl deletion was not 
seen when DBA/2 LPS blasts were omitted from the inoculum 
of LEW  FL cells. 
As a check for the sensitivity of the PCR technique,  we 
monitored Vfl deletion by FACS  |  analysis using an anti-Vfl8.2 
mAb.  A  summary of the  data is shown  in Table 3.  It can 
be seen that, relative to Mtv-7-  chimeras (e.g., LEW FL  + 
BALB/c B  cell blasts --* SCID),  there was  strong  deletion 
of  Vf18.2 +  cells  in  the  Mtv-7 +  chimeras  (LEW  FL  + 
DBA/2  B  cell blasts  --* SCID);  this  applied  to both CD4 
and CD8 cells. With regard to other Vfls, it is evident that 
the deletion of VflS.2 + cells was accompanied by increased 
expression of Vfll0 + cells.  The data on Vfll6 expression is 
discussed  below. 
VI3 Deletion  to  Other Mtv  Antigens.  Although  C.B-17 
SCID and BALB/c mice lack Mtv-7  antigens,  these strains 
59  Surh et al. Table  2.  Rat  TCR  Vfl Repertoire Analysis  in LN of Normal Rats and Rat FL  --" SCID Mouse  Chimeras as Determined 
by Semiquantitative  PCR Analysis 
Lewis  FL  + 
Lewis  FL  DBA/2  B  cell  F344  FL 
V/3  Lewis  ~  SCID  blasts  ~  SCID  V~8  F344  -~  SCID 
1  3  3  1  1  2  3 
2  9  11  8  2  5  6 
3.3  3  2  1  3.3  5  3 
4  11  8  1  4  8  3 
5.1+5.2  4  1  0  5.1+5.2  6  1 
6  10  18  2  6  8  16 
7  1  1  0  7  2  5 
8.2*  5  6  1  8.2*  8  14 
8.5  5  4  3  8.5  4  4 
8.6  3  3  2  8.6  2  4 
9  5  5  1  9  4  5 
10  8  10  10  10  5  6 
11  1  2  0  11  3  4 
12  2  0  0  12  5  0 
13  5  4  5  13  1  0 
14  5  4  20  14  6  3 
15  5  5  20  15  4  4 
16  6  2  2  16  6  2 
17  2  2  15  17  4  3 
18  2  2  4  18  3  2 
19  5  6  2  19  6  8 
20  2  3  1  20  3  4 
Unseparated  LN cells from normal rats or the xenochimeras  were analyzed for the presence of each rat TCR V/~ chain mRNA by a PCR method 
using rat VB-specific primers  as described in Materials and Methods.  The values detected for each V~ chains are the percentages  of combined  total 
TCR V/Ss. Xenochimeras  were generated  as described  in Table 1. 
The oligonucleotide primer used  for detection of V/38.2  also recognizes  a recently  described  Lewis  V~8 pseudogene,  V~510C (24). 
Table  3.  Rat  T  Cell Repertoire in LN of Normal Rats and Rat FL  ~  SCID Xenochimeras as Determined  by FACS  |  Analysis 
Lewis  FL +  Lewis  FL + 
T  cell  Normal  Lewis  FL  BALB/c B  cell  DBA/2  B  cell  Normal  F344  FL 
VB  subsets  Lewis  --~ SCID  blasts  ~  SCID  blasts  --~ SCID  F344  ~  SCID 
8.2  CO4  5.40  6.75  7.52  1.59  (79%)*  7.97  9.42 
CD8  4.71  7.34  7.00  1.99  (72o/0) *  4.17  6.38 
16  CD4  9.36  2.49  (73%)  0.29  (97%)  1.25  (87%)  8.65  1.32  (85%) 
CD8  8.20  3.53  (57%)  1.94  (76%)  2.93  (64%)  6.77  3.37  (44%) 
10  CD4  8.04  12.19  11.18  12.88  7.14  7.43 
CD8  3.30  5.10  5.82  7.45  3.30  3.75 
LN cells were double stained  for rat CD4 and rat TCR V~ chain using specific mAbs and analyzed  by FACScan |  as described in Materials and 
Methods. Values expressed are averages of two to four mice analyzed individually.  Data on CD8 cells were calculated as percentages of V/~ +  CD4-. 
Rat ~  mouse chimeras were generated as described in Table 1. Percent decreases of V/3 expression relative to normal rat LN cells are listed in parentheses. 
* Percent  decreases relative  to Lewis FL  +  BALB/c B cell blasts  "-~ SCID chimeras. 
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6,8,9  (4);  these, plus additional Mtv antigens, are also ex- 
pressed in the DBA/2 strain. Collectively, these antigens cause 
clonal deletion of V/33, 5, 11, 12, 16, and 17 T cells in mice. 
Deletion of these T cells tends to be most pronounced when 
the Mtv antigens are expressed  on B cells (reviewed in 19). 
The notable finding shown in Table 2 is that rat --~ mouse 
chimeras prepared with a tolerizing inoculum of DBA/2 B 
cell blasts display virtually the same pattern of V~ deletion 
seen in mice, i.e., deletion of V/3 3, 5, 11, 12, and 16 T cells. 
This pattern of deletion is less marked (or less complete) when 
mouse B cells are not coinjected with the FL cells (LEW 
FL ~  SCID, F344 FL ~  SCID). For V/316, FACS  |  analysis 
showed prominent deletion of V/316 cells in all of the chimeras, 
even when the chimeras did not receive mouse B cells (Table 
3).  V/316 deletion was  more pronounced for CD4 + cells 
than CD8 + (CD4-)  cells (Fig.  2,  top) and was evident in 
the thymus (for V/316  high cells ) (Fig.  2, bottom) as well as 
in LN. As a control, FACS  |  staining revealed no deletion 
of V/310 cells. In fact, as discussed above (Table 3), VB10 cells 
were enriched. By the PCR method, V/3 enrichment also 
applied  to V/314, V/315, and VB17 cells (Table 2). The en- 
richment for these cells was most pronounced when mouse 
B cells (DBA/2)  were coinjected with the rat FL cells. 
Discussion 
This paper documents that, by two different parameters, 
rat T cells tolerized to mouse H-2 antigens in xenochimeras 
are strongly reactive to mouse Mtv antigens. First, rat T cells 
depleted of H-2  a reactivity in Mtv-7-  hosts were able to 
mount primary proliferative responses  in vitro to Mtv-7 + 
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Lewis  -* SCID  B blasts ~  SCID 
vl~tl6  ,~"  . '~'! 
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Figure 2.  FACS  analysis  of rat V~ expression  in rat ~  mouse  chimeras. 
LN cells from normal Lewis  rats (a, d), Lewis  FL ~  SCID chimeras (b, 
e) and Lewis FL + BALB/c  B cell blasts -~ SCID chimeras (c, f) were 
double stained  for rat CD4 and rat VB16 (a-c) or V/310 (d-J). For thymo- 
cytes (g, h), unseparated  cells were stained for expression of rat V/316 and 
V/310. Stained cells were analyzed  with a FACScan  | 
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stimulator cells. Second,  rat T  cells exposed to mouse Mtv 
antigens during ontogeny exhibited an extensive pattern of 
V/3-specific clonal deletion. 
Although rat and mouse V~s display quite high amino 
acid homology (18), scattered sequence differences are apparent. 
Interestingly, these differences  are evident in the "fourth" 
hypervariable region (residues 72-74), i.e., the region impli- 
cated in binding to Mtv (Mtv-7) antigens (20, 21). This raises 
the possibility that additional residues are involved in V/3 rec- 
ognition of Mtv antigens (see 21). Evidence favoring this idea 
is presented in the accompanying paper. 
In view of the sequence differences between rat and mouse 
V/3s, the striking similarity in the V/3-specific response  of 
rat and mouse T  cells to Mtv antigens is surprising. With 
regard to immunogenic responses, rat T cells from rat FL 
C.B-17 SCID chimeras closely resembled normal C.B-17 and 
BALB/c T cells in giving primary proliferative  responses  in 
vitro to Mtv-7 (Mls a) antigens presented by BALB.D2 (and 
DBA/2) stimulators. In the accompanying paper,  evidence 
is presented that the proliferative  response  of rat T  cells to 
Mtv-7 is V/3 specific  and is largely restricted to V/36 and V~8.2 
T  cells. This is only slightly different from the response  of 
mouse T cells, where Mtv-7 responses are controlled predom- 
inantly by V/36 and V/38.1 T  cells. 
Rat T cell recognition of mouse Mtv antigens is especially 
pronounced in terms of tolerance induction. Indeed, the pat- 
terns of V~ deletion observed in rat --~ mouse chimeras were 
almost identical to the deletion patterns seen in normal mice. 
As in normal DBA/2 (Mtv-7 +) mice, the rat T  cells dif- 
ferentiating in LEW FL +  DBA/2 cell blasts ~  C.B-17 SCID 
mice displayed  strong deletion of Mtv-7-reactive cells, i.e., 
deletion of VB6,  7,  8  (8.2),  and 9 cells.  In addition, the 
chimeras showed deletion of V/3 3 (3.3),  4,  5,  11,  12, and 
16 cells. With the exception of V/34 cells, this same pattern 
of deletion is seen in normal DBA/2 mice, and is presumed 
to be directed to a spectrum of Mtv antigens, including Mtv-1, 
6,  8,  11, and 13.  Two points deserve comment. First, the 
chimeras were not depleted of V/317 + cells. This may indi- 
cate that rat V/317 is homologous to mouse V/317a2, which 
does not recognize Mtv antigens (22).  Second, V/3 deletion 
in rat ~  mouse chimeras was much less extensive when the 
chimeras were not coinjected with mouse B cells. This is in 
agreement with the evidence that, for Mtv antigens, a full 
spectrum of V~ deletion requires  the presence  of B cells. 
In view of.the extensive VB deletion in the chimeras, it 
is not surprising that some V/3s were elevated.  In Mtv-7 
chimeras (LEW FL ~  SCID, F344 FL ~  SCID), there was 
a substantial elevation of V/36 + cells. The increase in these 
cells could be a reflection of enhanced positive selection in 
the thymus. Thus, a number of groups have concluded that 
positive selection of V/36  + cells is  higher in I-E +  strains 
(e.g.,  C.B-17) than in I-E-  strains (reviewed in 4). In Mtv- 
7 + chimeras, i.e., LEW FL +  DBA/2 B cell blasts --~ SCID 
chimeras,  the extensive  deletion of V/36 + cells (and other 
VBs)  was paralleled  by a conspicuous increase  in V/314 +, 
15 +,  and 17 + cells.  Since these V/3s were not elevated  in 
Mtv-7-  chimeras (LEW FL --~ SCID), it is difficult to at- 
tribute the increased levels of these cells to enhanced positive selection. In this situation, the proportional increase in cer- 
tain V/3s could simply reflect the massive deletion of other Vj3s. 
Since infectious and endogenous Mtv are conspicuous only 
in mice, the question arises whether Mtv genes and mouse 
TCR genes have coevolved. Mutual coevolution seems un- 
likely. Thus,  the ability of rat and human T  cells to recog- 
nize mouse Mtv antigens (this paper, the accompanying paper, 
and reference 11) implies that the V/3 binding sites for Mtv 
and other superantigens are highly conserved between spe- 
cies (4). Hence there is no necessity to postulate that the mouse 
TCR has evolved to bind Mtv antigens.  As discussed else- 
where the reverse is more likely, i.e., that the virus has evolved 
to bind to the TCR.  This might  enable infectious viruses 
to be carried from the gut to mammary tissue via T  or B 
blast  cells (23). 
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